250 related articles for article (PubMed ID: 27553512)
1. Determinants of disability in cervical dystonia.
van den Dool J; Tijssen MA; Koelman JH; Engelbert RH; Visser B
Parkinsonism Relat Disord; 2016 Nov; 32():48-53. PubMed ID: 27553512
[TBL] [Abstract][Full Text] [Related]
2. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.
van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591
[TBL] [Abstract][Full Text] [Related]
3. The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia.
Werle RW; Takeda SY; Zonta MB; Guimarães AT; Teive HA
Arq Neuropsiquiatr; 2014 Jun; 72(6):405-10. PubMed ID: 24964104
[TBL] [Abstract][Full Text] [Related]
4. Cervical dystonia and quality of life.
Tomic S; Petkovic I; Pucic T; Resan B; Juric S; Rotim T
Acta Neurol Belg; 2016 Dec; 116(4):589-592. PubMed ID: 27138215
[TBL] [Abstract][Full Text] [Related]
5. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
Münchau A; Palmer JD; Dressler D; O'Sullivan JD; Tsang KL; Jahanshahi M; Quinn NP; Lees AJ; Bhatia KP
Brain; 2001 Apr; 124(Pt 4):769-83. PubMed ID: 11287376
[TBL] [Abstract][Full Text] [Related]
7. Decreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injections.
Häkkinen A; Ylinen J; Rinta-Keturi M; Talvitie U; Kautiainen H; Rissanen A
Arch Phys Med Rehabil; 2004 Oct; 85(10):1684-8. PubMed ID: 15468031
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.
Ceylan D; Erer S; Zarifoğlu M; Türkeş N; Özkaya G
Neurol Sci; 2019 Apr; 40(4):725-731. PubMed ID: 30659417
[TBL] [Abstract][Full Text] [Related]
9. [Cervical dystonia treatment with botulin toxin].
Tomczykiewicz K
Pol Merkur Lekarski; 2016 Aug; 41(242):107-10. PubMed ID: 27591450
[TBL] [Abstract][Full Text] [Related]
10. Cervical dystonia (spasmodic torticollis). Some aspects of the natural history.
Van Zandijcke M
Acta Neurol Belg; 1995 Dec; 95(4):210-5. PubMed ID: 8553794
[TBL] [Abstract][Full Text] [Related]
11. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
14. Cervical dystonia pathophysiology and treatment options.
Velickovic M; Benabou R; Brin MF
Drugs; 2001; 61(13):1921-43. PubMed ID: 11708764
[TBL] [Abstract][Full Text] [Related]
15. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospital.
Queiroz MR; Chien HF; Barbosa ER
Arq Neuropsiquiatr; 2011 Dec; 69(6):900-4. PubMed ID: 22297876
[TBL] [Abstract][Full Text] [Related]
17. Impaired heart rate variability in cervical dystonia is associated to depression.
Hentschel F; Dressler D; Abele M; Paus S
J Neural Transm (Vienna); 2017 Feb; 124(2):245-251. PubMed ID: 27816992
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation.
Odergren T; Tollbäck A; Borg J
Scand J Rehabil Med; 1994 Dec; 26(4):191-5. PubMed ID: 7878393
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study.
Smit M; Kuiper A; Han V; Jiawan VC; Douma G; van Harten B; Oen JM; Pouwels ME; Dieks HJ; Bartels AL; Tijssen MA
Parkinsonism Relat Disord; 2016 Sep; 30():7-12. PubMed ID: 27321988
[TBL] [Abstract][Full Text] [Related]
20. Cervical dystonia - improving the effectiveness of botulinum toxin therapy.
Tyślerowicz M; Kiedrzyńska W; Adamkiewicz B; Jost WH; Sławek J
Neurol Neurochir Pol; 2020; 54(3):232-242. PubMed ID: 32285434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
